Monopar Therapeutics (MNPR) — 10-K Filings
All 10-K filings from Monopar Therapeutics. Browse 1 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (1)
-
Monopar Therapeutics Files 2024 10-K
— Mar 31, 2025 Risk: medium
Monopar Therapeutics filed its 2024 10-K, reporting total assets of $14,338,403 as of December 31, 2024. The company had cash and cash equivalents of $6,102,560
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX